DRUG · Unmapped registry intervention
Tenofovir DF and Emtricitabine; Ritonavir-boosted Atazanavir
Find medicine records ·
Find other trials using this name
Clinical trial
Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV
NCT01602822
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedSafety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HIVunresolved
Interventions
Sponsors & collaborators
Kenneth H. Mayer, MDlead sponsor
Bristol-Myers Squibbcollaborator
Gilead Sciencescollaborator
Abbottcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01602822 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.